Trial Profile
Analysis of the immune response to Fendrix as compared to double-dose Engerix B in HIV-infected non-responders to standard Hepatitis B vaccination courses
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2017
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 08 Feb 2017 Planned number of patients changed from 30 to 10.
- 25 Oct 2015 Accrual to date is 3% according to United Kingdom Clinical Research Network record.
- 15 Oct 2014 New trial record